Measles cases in the United States have reached a 35-year high, with more than 5,000 cases and eight related deaths reported as of Nov. 14, 2026. Data shows a significant increase from 2025, when the country recorded 2,289 cases, and 2024, when 285 cases were reported. Health officials noted that while the disease was considered eliminated from the U.S. in 2000, current outbreaks are occurring domestically rather than being limited to cases imported by travelers.
Medical professionals report that 38% to 40% of measles cases this year have occurred in adults. In 2025, adults accounted for just over half of all measles-related hospitalizations. Dr. Gavin Harris of Emory Healthcare stated that adults are infected at rates similar to or higher than children and can face severe complications, including pneumonia and encephalitis, a type of brain swelling. One death reported this year involved an unvaccinated 40-year-old woman.
The measles, mumps, and rubella (MMR) vaccine is the primary preventive measure, with two doses estimated to be 97% effective. The standard schedule involves a first dose at 12 to 15 months of age and a second between ages 4 and 6. Experts, including Samantha Picking of Walgreens, stated that adults who have records of receiving two doses after their first birthday are considered protected for life and do not require a booster.
For those unsure of their vaccination status, physicians recommend checking state immunization registries or consulting healthcare providers. If records are unavailable, Dr. Harris noted that receiving an additional MMR dose is considered safe. Additionally, adults who received a version of the vaccine administered between 1963 and 1967 are encouraged to seek a booster, as that specific formulation was not fully effective. Conversely, individuals born before 1957 are generally considered immune due to widespread exposure before the vaccine existed.
The rise in measles cases affects unvaccinated adults and children, as well as those with incomplete medical records who may lack immunity to one of the most contagious known illnesses. With more than 5,000 cases reported so far in 2026—a nearly 60-fold increase from the 85 cases recorded in 2000—the scale of the outbreak has shifted from isolated travel-related incidents to domestic spread. Adults now represent approximately 40% of these cases, and in the previous year, they made up more than 50% of hospitalizations.
An unvaccinated person exposed to the virus has a narrow window for intervention, requiring a vaccine within three days or intravenous immunoglobulin (IVIG) within six days to prevent illness. For those without records, the cost of a "titer" blood test to check for antibodies may include lab fees and copays, leading some experts to suggest a booster shot as a more direct and safe alternative. These medical requirements can result in unplanned doctor visits and healthcare expenses for families trying to verify their immunity levels during active outbreaks.
The ongoing increase in cases follows the return of a disease once considered eliminated in the U.S. Health providers are currently urging adults to locate their records or consult pharmacists. Checking state registries or contacting childhood physicians to confirm two-dose MMR completion are among the steps recommended for the public as the 2026 infection numbers continue to rise.
